Vilin Bio Med

{
  "main_header": {
    "sid": 1003873,
    "name": "Vilin Bio Med",
    "stock_name": "Vilin Bio Med",
    "full_name": "Vilin Bio Med Ltd",
    "name_url": "stocks-analysis/vilin-bio-med",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.00",
    "chg": 1.65,
    "chgp": "4.95%",
    "dir": 1,
    "prev_price": "33.35",
    "mcapval": "47.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "VILINBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0L4V01013",
    "curr_date": "Feb 04",
    "curr_time": "",
    "bse_nse_vol": 36000,
    "exc_status": "Active",
    "traded_date": "Feb 04, 2026",
    "traded_date_str": "2026 02 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vilin-bio-med-1003873-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Vilin Bio Med?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vilin-bio-med-3695750",
        "imagepath": "",
        "date": "2025-11-13 00:38:08",
        "description": "Answer:\nThe historical performance of Vilin Bio Med shows a fluctuating trend in key financial metrics over the past five years.\n\nBreakdown:\nVilin Bio Med's net sales have shown a general increase from INR 11.21 crore in March 2022 to INR 15.80 crore in March 2024, before slightly declining to INR 14.81 crore in March 2025. The total operating income followed a similar trend, peaking in March 2024. However, the raw material costs have risen significantly, from INR 9.06 crore in March 2021 to INR 13.47 crore in March 2025, impacting the operating profit, which decreased from INR 2.59 crore in March 2023 to INR 1.25 crore in March 2025. Profit before tax also declined from INR 1.78 crore in March 2023 to INR 0.31 crore in March 2025, while profit after tax dropped from INR 1.25 crore in March 2023 to INR 0.22 crore in March 2025. The company's total liabilities decreased from INR 32.40 crore in March 2024 to ..."
      }
    ],
    "total": 68,
    "sid": "1003873",
    "stock_news_url": "https://www.marketsmojo.com/news/vilin-bio-med-1003873"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

How has been the historical performance of Vilin Bio Med?

2025-11-13 00:38:08

Answer: The historical performance of Vilin Bio Med shows a fluctuating trend in key financial metrics over the past five years. Breakdown: Vilin Bio Med's net sales have shown a general increase from INR 11.21 crore in March 2022 to INR 15.80 crore in March 2024, before slightly declining to INR 14.81 crore in March 2025. The total operating income followed a similar trend, peaking in March 2024. However, the raw material costs have risen significantly, from INR 9.06 crore in March 2021 to INR 13.47 crore in March 2025, impacting the operating profit, which decreased from INR 2.59 crore in March 2023 to INR 1.25 crore in March 2025. Profit before tax also declined from INR 1.78 crore in March 2023 to INR 0.31 crore in March 2025, while profit after tax dropped from INR 1.25 crore in March 2023 to INR 0.22 crore in March 2025. The company's total liabilities decreased from INR 32.40 crore in March 2024 to ...

Read full news article

View All News